Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China.
Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Theranostics. 2020 Oct 26;10(26):11976-11997. doi: 10.7150/thno.50663. eCollection 2020.
Rapid increase in aging populations is an urgent problem because older adults are more likely to suffer from disabilities and age-related diseases (ARDs), burdening healthcare systems and society in general. ARDs are characterized by the progressive deterioration of tissues and organs over time, eventually leading to tissue and organ failure. To date, there are no effective interventions to prevent the progression of ARDs. Hence, there is an urgent need for new treatment strategies. Ferroptosis, an iron-dependent cell death, is linked to normal development and homeostasis. Accumulating evidence, however, has highlighted crucial roles for ferroptosis in ARDs, including neurodegenerative and cardiovascular diseases. In this review, we a) summarize initiation, regulatory mechanisms, and molecular signaling pathways involved in ferroptosis, b) discuss the direct and indirect involvement of the activation and/or inhibition of ferroptosis in the pathogenesis of some important diseases, and c) highlight therapeutic targets relevant for ARDs.
人口老龄化的迅速增加是一个紧迫的问题,因为老年人更容易患上残疾和与年龄相关的疾病(ARDs),给医疗保健系统和整个社会带来负担。ARDs 的特征是随着时间的推移组织和器官逐渐恶化,最终导致组织和器官衰竭。迄今为止,尚无有效的干预措施来阻止 ARDs 的进展。因此,迫切需要新的治疗策略。铁死亡是一种依赖铁的细胞死亡,与正常发育和内稳态有关。然而,越来越多的证据表明铁死亡在 ARDs 中起着至关重要的作用,包括神经退行性疾病和心血管疾病。在这篇综述中,我们 a)总结了铁死亡的起始、调节机制和分子信号通路,b)讨论了铁死亡的激活和/或抑制在一些重要疾病发病机制中的直接和间接作用,c)强调了与 ARDs 相关的治疗靶点。